Clearmind Medicine Inc. (CMND)

CIK 0001892500 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023
FY-2023
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Statements of Financial Position
—
Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive Loss (P)
—
Statements of Changes In Shareholders Equity (deficit)
—
Consolidated Statements of Cash Flows
—
Notes
Capital Management
—
Commitments
—
Convertible Loans
—
Cybersecurity Risk Management and Strategy Disclosure
—
Derivative Warrant Liabilities
—
Financial Instruments and Risk Management
—
General and Administrative Expenses
—
Income Taxes
—
Insider Trading Policies and Procedures
—
Intangible Assets
—
Leases
—
Material Accounting Policies
—
Material Cybersecurity Incident Disclosure
—
Nature of Operations and Going Concern
—
Related Party Transactions
—
Research and Development
—
Research and Development, Net
—
Restricted Share Units
—
Segmented Information
—
Share Capital
—
Share Purchase Warrants
—
Short-term Investments
—
Significant Accounting Policies
—
Stock Options
—
Subsequent Events
—
Warrants
—